Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Learn Mem ; 19(12): 615-26, 2012 Nov 19.
Article in English | MEDLINE | ID: mdl-23166293

ABSTRACT

Na⁺-dependent high-affinity glutamate transporters have important roles in the maintenance of basal levels of glutamate and clearance of glutamate during synaptic transmission. Interestingly, several studies have shown that basal glutamate transport displays plasticity. Glutamate uptake increases in hippocampal slices during early long-term potentiation (E-LTP) and late long-term potentiation (L-LTP). Four issues were addressed in this research: Which glutamate transporter is responsible for the increase in glutamate uptake during L-LTP? In what cell type in the hippocampus does the increase in glutamate uptake occur? Does a single type of cell contain all the mechanisms to respond to an induction stimulus with a change in glutamate uptake? What role does the increase in glutamate uptake play during L-LTP? We have confirmed that GLT-1 is responsible for the increase in glutamate uptake during L-LTP. Also, we found that astrocytes were responsible for much, if not all, of the increase in glutamate uptake in hippocampal slices during L-LTP. Additionally, we found that cultured astrocytes alone were able to respond to an induction stimulus with an increase in glutamate uptake. Inhibition of basal glutamate uptake did not affect the induction of L-LTP, but inhibition of the increase in glutamate uptake did inhibit both the expression of L-LTP and induction of additional LTP. It seems likely that heightened glutamate transport plays an ongoing role in the ability of hippocampal circuitry to code and store information.


Subject(s)
Astrocytes/physiology , Excitatory Amino Acid Transporter 2/metabolism , Hippocampus/cytology , Long-Term Potentiation/physiology , Neurons/physiology , Alanine Transaminase/pharmacology , Analysis of Variance , Animals , Animals, Newborn , Aspartic Acid/pharmacology , Astrocytes/drug effects , Biophysics , Biotinylation , Cells, Cultured , Colforsin/pharmacology , Electric Stimulation , Excitatory Amino Acid Agonists/pharmacology , Excitatory Amino Acid Antagonists/pharmacology , Excitatory Amino Acid Transporter 1/metabolism , Excitatory Postsynaptic Potentials/drug effects , Flow Cytometry , Glial Fibrillary Acidic Protein/metabolism , Glutamates/pharmacology , Glutamic Acid/metabolism , Glycine/analogs & derivatives , Glycine/pharmacology , In Vitro Techniques , Indoles/pharmacology , Kainic Acid/analogs & derivatives , Kainic Acid/pharmacology , Long-Term Potentiation/drug effects , Male , Neurons/drug effects , Protein Transport/drug effects , Quinoxalines/pharmacology , Rats , Rats, Sprague-Dawley , Sodium Channel Blockers/pharmacology , Tetrodotoxin/pharmacology , Valine/analogs & derivatives , Valine/pharmacology
2.
Mol Brain ; 5: 13, 2012 Apr 26.
Article in English | MEDLINE | ID: mdl-22537872

ABSTRACT

Over-activation of AMPARs (α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid subtype glutamate receptors) is implicated in excitotoxic neuronal death associated with acute brain insults, such as ischemic stroke. However, the specific molecular mechanism by which AMPARs, especially the calcium-impermeable AMPARs, induce neuronal death remains poorly understood. Here we report the identification of a previously unrecognized molecular pathway involving a direct protein-protein interaction that underlies GluR2-containing AMPAR-mediated excitotoxicity. Agonist stimulation of AMPARs promotes GluR2/GAPDH (glyceraldehyde-3-phosphate dehydrogenase) complex formation and subsequent internalization. Disruption of GluR2/GAPDH interaction by administration of an interfering peptide prevents AMPAR-mediated excitotoxicity and protects against damage induced by oxygen-glucose deprivation (OGD), an in vitro model of brain ischemia.


Subject(s)
Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)/metabolism , Neurotoxins/toxicity , Protein Subunits/metabolism , Receptors, AMPA/metabolism , Animals , Cell Death/drug effects , Cells, Cultured , Endocytosis/drug effects , Extracellular Space/drug effects , Extracellular Space/metabolism , Glucose/deficiency , HEK293 Cells , Humans , Models, Biological , Neurons/drug effects , Neurons/metabolism , Oxygen/metabolism , Protein Binding/drug effects , Rats , Rats, Wistar , Receptors, AMPA/agonists , Transfection
3.
J Neurochem ; 117(5): 833-40, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21426345

ABSTRACT

The sodium-dependent glutamate transporter, glutamate transporter subtype 1 (GLT-1) is one of the main glutamate transporters in the brain. GLT-1 contains a COOH-terminal sequence similar to one in an isoform of Slo1 K(+) channel protein previously shown to bind MAGI-1 (membrane-associated guanylate kinase with inverted orientation protein-1). MAGI-1 is a scaffold protein which allows the formation of complexes between certain transmembrane proteins, actin-binding proteins, and other regulatory proteins. The glutathione S-transferase pull-down assay demonstrated that MAGI-1 was a binding partner of GLT-1. The interaction between MAGI-1 and GLT-1 was confirmed by co-immunoprecipitation. Immunofluorescence of MAGI-1 and GLT-1 demonstrated that the distribution of MAGI-1 and GLT-1 overlapped in astrocytes. Co-expression of MAGI-1 with GLT-1 in C6 Glioma cells resulted in a significant reduction in the surface expression of GLT-1, as assessed by cell-surface biotinylation. On the other hand, partial knockdown of endogenous MAGI-1 expression by small interfering RNA in differentiated cultured astrocytes increased glutamate uptake and the surface expression of endogenous GLT-1. Knockdown of MAGI-1 increased dihydrokainate-sensitive, Na(+) -dependent glutamate uptake, indicating that MAGI-1 regulates GLT-1 mediated glutamate uptake. These data suggest that MAGI-1 regulates surface expression of GLT-1 and the level of glutamate in the hippocampus.


Subject(s)
Excitatory Amino Acid Transporter 1/biosynthesis , Guanylate Kinases/biosynthesis , Membrane Proteins/biosynthesis , Animals , Astrocytes/metabolism , Biotinylation , Cell Line, Tumor , Cells, Cultured , Excitatory Amino Acid Transporter 1/genetics , Excitatory Amino Acid Transporter 3/biosynthesis , Excitatory Amino Acid Transporter 3/genetics , Fluorescent Antibody Technique , Gene Expression Regulation , Glioma/metabolism , Glutamic Acid/metabolism , Glutathione Transferase/metabolism , Guanylate Kinases/genetics , Hippocampus/cytology , Hippocampus/metabolism , Immunoprecipitation , Large-Conductance Calcium-Activated Potassium Channel alpha Subunits/biosynthesis , Large-Conductance Calcium-Activated Potassium Channel alpha Subunits/genetics , Membrane Proteins/genetics , Plasmids/genetics , RNA, Small Interfering/pharmacology , Rats , Recombinant Fusion Proteins/biosynthesis , Recombinant Fusion Proteins/chemistry , Transfection
4.
Mol Pharmacol ; 73(2): 369-78, 2008 Feb.
Article in English | MEDLINE | ID: mdl-17989350

ABSTRACT

Large-conductance Ca(2+)-activated K(+) (BK(Ca)) channels encoded by the Slo1 gene are ubiquitously expressed, and they play a role in regulation of many cell types. In excitable cells, BK(Ca) channels and voltage-activated Ca(2+) channels often form functional complexes that allow the cytoplasmic domains of BK(Ca) channels to lie within spatially discrete calcium microdomains. Here, we report a novel protein interaction between the beta1-subunit of L-type voltage-activated calcium channels (Ca(v)beta1) and critical regulatory domains of Slo1 that can occur in the absence of other proteins. This interaction was identified by a yeast two-hybrid screen, and it was confirmed by confocal microscopy in native neurons, by coimmunoprecipitation, and by direct binding assays. The Ca(v)beta1 subunit binds within the calcium bowl domain of Slo1 that mediates a portion of high-affinity Ca(2+) binding to BK(Ca) channels and also to a noncanonical Src homology 3 (SH3) domain-binding motif within Slo1. Binding of Ca(v)beta1 markedly slows Slo1 activation kinetics, and it causes a significant decrease in Ca(2+) sensitivity in inside-out and in dialyzed cells, even in the absence of pore-forming subunits of voltage-gated Ca(2+) channels. The guanylate kinase domain of Ca(v)beta1 mediates Slo1 regulation through its binding to calcium bowl domains, and this domain of Ca(v)beta1 is necessary and sufficient for the observed effects on BK(Ca) activation. Binding of Ca(v)beta1 to SH3-binding motifs may stabilize the interaction with Slo1, or it may contribute to formation of other complexes, but it does not seem to affect Ca(2+)-dependent gating of Slo1. Binding of Ca(v)beta1 does not affect cell surface expression of Slo1 in human embryonic kidney 293T cells.


Subject(s)
Calcium Channels, L-Type/metabolism , Ion Channel Gating/physiology , Potassium Channels, Calcium-Activated/antagonists & inhibitors , Potassium Channels, Calcium-Activated/metabolism , Protein Subunits/metabolism , Calcium Channels, L-Type/genetics , Cell Line , Humans , Ion Channel Gating/genetics , Membrane Potentials/genetics , Potassium Channels, Calcium-Activated/genetics , Protein Binding/genetics , Protein Subunits/genetics , Protein Subunits/physiology
5.
Mol Pharmacol ; 73(2): 359-68, 2008 Feb.
Article in English | MEDLINE | ID: mdl-17989352

ABSTRACT

Large-conductance Ca(2+)-activated K(+) (BK(Ca)) channels regulate the physiological properties of many cell types. The gating properties of BK(Ca) channels are Ca(2+)-, voltage- and stretch-sensitive, and stretch-sensitive gating of these channels requires interactions with actin microfilaments subjacent to the plasma membrane. Moreover, we have previously shown that trafficking of BK(Ca) channels to the plasma membrane is associated with processes that alter cytoskeletal dynamics. Here, we show that the Slo1 subunits of BK(Ca) channels contain a novel cytoplasmic actin-binding domain (ABD) close to the C terminus, considerably downstream from regions of the channel molecule that play a major role in determining channel-gating properties. Binding of actin to the ABD can occur in a binary mixture in the absence of other proteins. Coexpression of a small ABD-green fluorescent protein fusion protein that competes with full-length Slo1 channels for binding to actin markedly suppresses trafficking of full-length Slo1 channels to the plasma membrane. In addition, Slo1 channels containing deletions of the ABD that eliminate actin binding are retained in intracellular pools, and they are not expressed on the cell surface. At least one point mutation within the ABD (L1020A) reduces surface expression of Slo1 channels to approximately 25% of wild type, but it does not cause a marked effect on the gating of point mutant channels that reach the cell surface. These data suggest that Slo1-actin interactions are necessary for normal trafficking of BK(Ca) channels to the plasma membrane and that the mechanisms of this interaction may be different from those that underlie F-actin and stretch-sensitive gating.


Subject(s)
Actins/biosynthesis , Cell Membrane/metabolism , Gene Expression Regulation/physiology , Large-Conductance Calcium-Activated Potassium Channel alpha Subunits/biosynthesis , Large-Conductance Calcium-Activated Potassium Channel alpha Subunits/chemistry , Actins/genetics , Binding Sites/physiology , Cell Line , Cell Membrane/genetics , Cells, Cultured , Humans , Large-Conductance Calcium-Activated Potassium Channel alpha Subunits/genetics , Potassium Channels, Calcium-Activated/biosynthesis , Potassium Channels, Calcium-Activated/genetics , Protein Binding/physiology , Protein Structure, Tertiary/genetics
6.
J Neurophysiol ; 97(5): 3508-16, 2007 May.
Article in English | MEDLINE | ID: mdl-17329633

ABSTRACT

Auxiliary (beta) subunits of large-conductance Ca(2+)-activated K(+) (BK(Ca)) channels regulate the gating properties of the functional channel complex. Here we show that an avian beta1-subunit also stimulates the trafficking of BK(Ca) channels to the plasma membrane in HEK293T cells and in a native population of developing vertebrate neurons. One C-terminal variant of BK(Ca) alpha-subunits, called the VEDEC isoform after its five last residues, is largely retained in intracellular compartments when it is heterologously expressed in HEK293T cells. A closely related splice variant, called QEERL, shows high levels of constitutive trafficking to the plasma membrane. Co-expression of beta1-subunits with the VEDEC isoform resulted in a large increase in surface BK(Ca) channels as assessed by cell-surface biotinylation assays, whole cell recordings of membrane current, and confocal microscopy in HEK293T cells. Co-expression of beta1-subunits slowed the gating kinetics of BK(Ca) channels, as reported previously. Consistent with this, overexpression of beta1-subunits in a native cell type that expresses intracellular VEDEC channels, embryonic day 9 chick ciliary ganglion neurons, resulted in a significant increase in macroscopic Ca(2+)-activated K(+) current. Both the cytoplasmic N- and C-terminal domains of avian beta1 are able to bind directly to VEDEC and QEERL channels. However, overexpression of the N-terminal domain by itself is sufficient to stimulate trafficking of VEDEC channels to the plasma membrane, whereas overexpression of either the cytoplasmic C-terminal domain or the extracellular loop domain did not affect surface expression of VEDEC.


Subject(s)
Cell Membrane/metabolism , Gene Expression/physiology , Large-Conductance Calcium-Activated Potassium Channel beta Subunits/metabolism , Protein Subunits/physiology , Analysis of Variance , Biotinylation/methods , Cell Line, Transformed , Cell Membrane/genetics , Green Fluorescent Proteins/biosynthesis , Humans , Immunoprecipitation/methods , Large-Conductance Calcium-Activated Potassium Channel beta Subunits/genetics , Membrane Potentials/drug effects , Membrane Potentials/physiology , Membrane Potentials/radiation effects , Mutation/physiology , Patch-Clamp Techniques , Protein Transport/drug effects , Protein Transport/physiology , Transfection/methods
7.
J Neurosci ; 25(17): 4385-95, 2005 Apr 27.
Article in English | MEDLINE | ID: mdl-15858065

ABSTRACT

here is considerable evidence that dopamine D2 receptors can modulate AMPA receptor-mediated neurotoxicity. However, the molecular mechanism underlying this process remains essentially unclear. Here we report that D2 receptors inhibit AMPA-mediated neurotoxicity through two pathways: the activation of phosphoinositide-3 kinase (PI-3K) and downregulation of AMPA receptor plasma membrane expression, both involving a series of protein-protein coupling/uncoupling events. Agonist stimulation of D2 receptors promotes the formation of the direct protein-protein interaction between the third intracellular loop of the D2 receptor and the ATPase N-ethylmaleimide-sensitive factor (NSF) while uncoupling the NSF interaction with the carboxyl tail (CT) of the glutamate receptor GluR2 subunit of AMPA receptors. Previous studies have shown that full-length NSF directly couples to the GluR2CT and facilitates AMPA receptor plasma membrane expression. Furthermore, the CT region of GluR2 subunit is also responsible for several other intracellular protein couplings, including p85 subunit of PI-3K. Therefore, the direct coupling of D2-NSF and concomitant decrease in the NSF-GluR2 interaction results in a decrease of AMPA receptor membrane expression and an increase in the interaction between GluR2 and the p85 and subsequent activation of PI-3K. Disruption of the D2-NSF interaction abolished the ability of D2 receptor to attenuate AMPA-mediated neurotoxicity by blocking the D2 activation-induced changes in PI-3K activity and AMPA receptor plasma membrane expression. Furthermore, the D2-NSF-GluR2-p85 interactions are also responsible for the D2 inhibition of ischemia-induced cell death. These data may provide a new avenue to identify specific targets for therapeutics to modulate glutamate receptor-governed diseases, such as stroke.


Subject(s)
Excitatory Amino Acid Agonists/toxicity , Receptors, AMPA/physiology , Receptors, Dopamine D2/physiology , alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid/toxicity , Animals , Apoptosis/drug effects , Apoptosis/physiology , Blotting, Western/methods , Brain/cytology , Brain/physiology , Cells, Cultured , Dopamine Agonists/pharmacology , Dopamine Antagonists/pharmacology , Dose-Response Relationship, Drug , Drug Interactions , Embryo, Mammalian , Enzyme Inhibitors/pharmacology , Enzyme-Linked Immunosorbent Assay/methods , GABA Antagonists/pharmacology , Glucose/deficiency , Glutathione Transferase/metabolism , Humans , Hypoxia , Immunoprecipitation/methods , N-Ethylmaleimide-Sensitive Proteins/metabolism , Phosphatidylinositol 3-Kinases/metabolism , Picrotoxin/pharmacology , Propidium , Protein Binding/drug effects , Protein Binding/physiology , Quinpirole/pharmacology , Raclopride/pharmacology , Radioligand Assay/methods , Rats , Rats, Wistar , Receptors, AMPA/classification , Recombinant Fusion Proteins/metabolism
8.
Neuron ; 43(1): 43-55, 2004 Jul 08.
Article in English | MEDLINE | ID: mdl-15233916

ABSTRACT

CA1 pyramidal neurons degenerate after transient global ischemia, whereas neurons in other regions of the hippocampus remain intact. A step in this selective injury is Ca(2+) and/or Zn(2+) entry through Ca(2+)-permeable AMPA receptor channels; reducing Ca(2+) permeability of AMPA receptors via expression of Ca(2+)-impermeable GluR2(R) channels or activation of CRE transcription in the hippocampus of adult rats in vivo using shutoff-deficient pSFV-based vectors rescues vulnerable CA1 pyramidal neurons from forebrain ischemic injury. Conversely, the induction of Ca(2+) and/or Zn(2+) influx through AMPA receptors by expressing functional Ca(2+)-permeable GluR2(Q) channels causes the postischemic degeneration of hippocampal granule neurons that otherwise are insensitive to ischemic insult. Thus, the AMPA receptor subunit GluR2 gates entry of Ca(2+) and/or Zn(2+) that leads to cell death following transient forebrain ischemia.


Subject(s)
Calcium Channels/metabolism , Calcium Signaling/genetics , Ischemic Attack, Transient/metabolism , Prosencephalon/metabolism , Receptors, AMPA/metabolism , Animals , Animals, Newborn , Calcium/metabolism , Calcium Channels/genetics , Calcium Channels, Q-Type/genetics , Calcium Channels, Q-Type/metabolism , Cell Death/genetics , Cell Membrane Permeability/genetics , Cyclic AMP Response Element-Binding Protein/genetics , Cyclic AMP Response Element-Binding Protein/metabolism , Cyclin-Dependent Kinase 5 , Cyclin-Dependent Kinases/genetics , Cyclin-Dependent Kinases/metabolism , Disease Models, Animal , Hippocampus/metabolism , Hippocampus/physiopathology , In Vitro Techniques , Integrases/genetics , Integrases/metabolism , Ion Channel Gating/genetics , Ischemic Attack, Transient/genetics , Ischemic Attack, Transient/pathology , Nerve Degeneration/genetics , Nerve Degeneration/metabolism , Nerve Degeneration/pathology , Prosencephalon/pathology , Protein Binding/genetics , Pyramidal Cells/metabolism , Pyramidal Cells/pathology , Rats , Rats, Sprague-Dawley , Receptors, AMPA/genetics , Zinc/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...